Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-06-10

Cancer After Transplantation

Obiettivo



Organ transplantation is followed by an increased risk for development of cancer. Analyses of materials from transplanted and therefore immunosuppressed patients allow the possibility to find risk factors for cancer and to evaluate oncogenetic mechanisms in general.

In our most recent analyses performed using correct cancer epidemiological methods an increased incidence of 3 - 5 times that in the general population has been found, including most types of tumours, however with an uneven pattern with emphasis on lip- cervical-, vulvar-, urological-, skin-cancers and lymphoproliferative disorders (PTLD). Most tumours occur early (include. PTLD) after transplantation, tumours of the skin however later and with an increase with time.

This complication appears to be increasing in degree for all types of organ transplantation, however a parallel increase in our knowledge concerning possible risk factors and oncogenetic mechanisms in general. Many of the tumours appear to be associated in some way with virus infections, thus opening up for possible new approaches to prophylaxis and treatment.

Based on previous cancer epidemiological studies in the Nordic countries it is the aim of this new study to :

1. perform a follow-up on existing files on kidney transplanted patients in the Nordic countries to latest possible date in the framework of Scandiotransplant and the Association of the Nordic cancer Registries

2. to analyse the Nordic material concerning all types of organ transplantation to latest possible date in the framework of Scandiatransplant and the Association of the Nordic Cancer Registries (ANCR)

3. to start a prospective registry with extensive use of existing data files in the Scandiatransplant organisation and the Association of the Nordic Cancer Registries (ANCR) allowing yearly analysis, with 1-3 in a collaborative study including all Nordic transplantation centres and cancer registries

4. to perform a study of cancer in patients on dialysis in the European Institute of Oncology, Division of Epidemiology and Biostatistics in Milano, Italy, which co-operates with centres in many European countries, since this will be complementary to the transplant study, as these patients are uremic with depressed immune defence, however not transplanted and immunosuppressed by drugs.

The cancer epidemiological analysis will allow identification of cases to be analysed intensively in :

5. specialised laboratories for immune pathology (DK, GB), cytokines (DK), virology (DK), and tissue typing (DK, FI, N, SE)

6. identified cases with proved Epstein-Barr oncogenetic background will be treated with a combination of (a) intravenous high-dose aciclovir and (b) decreased or discontinued immunosuppression.

The overall aim is to bring together cancer epidemiology (in the Nordic countries and Italy) with new advances in cellular, molecular and developmental genetics in immunopathology and immunology (cytokines and tissue types) and virology in order to obtain new biological insights and improvements in both diagnosis and treatment of interest for the field of transplantation and thereby also to obtain new insights in oncogenesis per se.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CON - Coordination of research actions

Coordinatore

Odense University Hospital
Contributo UE
Nessun dato
Indirizzo
Odense University Hospital
5000 ODENSE
Danimarca

Mostra sulla mappa

Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato
Il mio fascicolo 0 0